Anti-CD20 [18B12]

Ended Purchase Order Awarded Last action

Contract number
75N93021P00808
Awardee
Awarding agency
Obligated
$14,310

Award facts

Opportunity
  • RFQ2076939 Solicitation number
Contract value 100% obligated
$14,310.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325414 Biological Product (except Diagnostic) Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
Total Small Business
Competition
Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Boston, MA 02210, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00001 -$100
Original award $14,410

Quick answers

Who was awarded contract 75N93021P00808?

75N93021P00808 was awarded to Kerafast Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on June 11, 2021.

How much is contract 75N93021P00808 worth?

The government has obligated $14,310 on 75N93021P00808.

Was contract 75N93021P00808 competed?

The extent of competition for 75N93021P00808 was competed under sap. The government received 1 offer. It was set aside: Total Small Business.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award